PHRRF (PharmaTher Holdings) Common Stock: $6.56 Mil (As of Feb. 2026)


What is PharmaTher Holdings Common Stock?

PharmaTher Holdings PHRRF +0.54% Common Stock is $6.56 Mil as of Feb. 2026. The stock has 2 warning signs investors should review.

PharmaTher Holdings's quarterly common stock declined from Aug. 2025 ($6.49 Mil) to Nov. 2025 ($6.37 Mil) but then increased from Nov. 2025 ($6.37 Mil) to Feb. 2026 ($6.56 Mil).

PharmaTher Holdings's annual common stock declined from May. 2023 ($6.25 Mil) to May. 2024 ($6.22 Mil) and declined from May. 2024 ($6.22 Mil) to May. 2025 ($6.13 Mil).

PharmaTher Holdings Common Stock Historical Data

* Premium members only.

The historical data trend for PharmaTher Holdings's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaTher Holdings Common Stock Chart

PharmaTher Holdings Annual Data
Trend May21 May22 May23 May24 May25
Common Stock
1.95 6.57 6.25 6.22 6.13

PharmaTher Holdings Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.95 6.13 6.49 6.37 6.56

PharmaTher Holdings Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $6.56 Mil mean?
PharmaTher Holdings (PHRRF) has a Common Stock of $6.56 Mil as of Feb. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on PharmaTher Holdings and its competitors.
Is PharmaTher Holdings' Common Stock too high?
PharmaTher Holdings' current Common Stock is $6.56 Mil.
How does PharmaTher Holdings' Common Stock compare to VRTX and REGN?
PharmaTher Holdings' Common Stock of $6.56 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on PharmaTher Holdings and its competitors. PharmaTher Holdings's current Common Stock is $6.56 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaTher Holdings stock overvalued right now?
PharmaTher Holdings (PHRRF) has a current Common Stock of $6.56 Mil. The current Common Stock is $6.56 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For PharmaTher Holdings (PHRRF), the current Common Stock is $6.56 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PharmaTher Holdings Business Description

Other Exchanges NCC0:GermanyPHRM:Canada
Address 82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat mental health, neurological, and pain disorders. Its product pipeline includes Ketamine, KETABET, Microneedle Patch and others.